Taiwan alternatives to animal testing (TAAT)-Webinar

Last update：2023.11.24

SOT Webinars

Title	Topic	Update
Emerging Toxicological Science: Challenges in Food and Ingredient Safety		2023.11.24
21st Century Toxicology: Sneak Preview of Ongoing Relevant Activities		2023.7.25
Do Per- and Poly-fluoroalkyl Substances (PFAS) Cause Cancer in Humans?		2022.8.24
The Predictive Toxicogenomics Space (PTGS) Modeling Tool Captures Diverse Cellular and Organ Toxicity Mechanisms and Serves for In Vitro Model-Driven Prediction of Drug-Induced Liver Injury		2022.6.22
Dermal Absorption and Toxicology In Vitro; What are the Tests, How Can We Use Them and Where are the Innovations?		2022.6.14
International Advances in Alternatives and a Next Generation Risk Assessment Case Study for Skin Allergy		2022.6.8
Integrating Computational Tools into Carcinogenicity Assessments		2022.4.11
Inhalation Toxicity: In Vitro to Human Risk Assessment		2022.4.7
Standardization of PBPK Modeling Practice		2022.3.14
Moving from One-Size-Fits-All to Fit-for Purpose TTC Values		2021.9.1
IVAM Webinar Series: The development and application of in vitro methods and non-animal models for toxicology and product safety	State of the Science: QSAR Modeling of Skin Sensitization -Pred-Skin: A Web Portal for Accurate Prediction of Human Skin Sensitizers -Evaluation of the Global Performance of Eight In Silico Skin Sensitization Models -Skin Sensitization In Silico Protocol	2021.6.8
	Big Data and Toxicology - Future is Now -A.I. and Big Data - New Kids on the Toxicology Block -Smart Chemistry - Algorithms for Chemical Classification and Clustering	2021.3.25

PCRM-NURA webinars

Title	Topic	Update
DyNAMic Discussions: The Future is Already here	Applications of ‘omics data to assess toxicology and ecological health	2023.11.3
	Using NAMs to Solve Regulatory Challenges: Quantitative Investigations of PFAS chemicals	2023.10.24
	New Strategies for Safety Assessments of EDCs	2023.10.18
	Ecotox: What can we do today?	2023.5.17
	Frameworks for Establishing Scientific Confidence in New Approach Methodologies: PART II	2023.4.21
	Frameworks for Establishing Scientific Confidence in New Approach Methodologies: PART I	2023.4.13
	Moving beyond tick-box toxicology: Stakeholder partnerships to facilitate fit for purpose solutions	2023.4.7
	Integrated Approaches for Testing and Assessment (IATA): NAM-based safety assessment frameworks	2022.12.29
	NAMs as the new Gold Standard: Bringing validation into the 21st century	2022.11.30
	DART: What can we do today?	2022.11.8
	DyNAMmic Discussions: NAM-centered paradigms for regulatory decision-making: Leaving the animal tests behind	2022.8.18
Tomorrow's Data, Today: Sunsetting the 2-year Carcinogenicity Assay		2023.7.5
Human In, Human Out: Using Primary and Population Data for PBPK Analyses		2023.4.10
ICE, ICE, Data: Using NICEATM’s Integrated Chemical Environment to support chemical evaluations		2022.6.20
New Approach Methodologies for Medical Devices		2022.3.1
「Nix the Six」：Strategies for Implementing a Non-animal Acute 6-Pack		2021.11.22

ASCCT Webinars(ASCCT/ESTIV)

Title	Update
Modeling of Adverse Outcomes - Insights from the ONTOX Project	2023.9.27
Gaining Confidence in Advanced Methodologies for Studying Challenging Chemicals	2023.6.6
Award Winners’ Webinar: New approach methodologies for evaluating cardio- and developmental toxicity	2023.5.30
ASCCT Award Winners Webinar	2023.5.9
Using NAMs in Risk Assessment	2023.2.14
Modeling tools for better prediction of the kinetics and dynamics of xenobiotics	2022.12.6
Guidance and standards for increasing regulatory confidence in in vitro and PBK models	2022.11.21
Science for Policy, Policy for Science	2022.9.23
Advancing In Vitro Models for Genotoxicity and Carcinogenicity	2022.7.27
Development and evaluation of NAMs for new endpoints: Developmental neurotoxicity and respiratory sensitization	2022.6.2
Maturing three-dimensional toxicology models of the barrier organs: Examples from lung and skin	2022.4.21
Serum-Free Cultures: Why and How?	2022.4.21
Advances in Genotoxicity: Reconstructed Skin Comet and Micronucleus Assays	2022.2.23
Development and application of in vitro data	2022.2.23
How to Control and to Maintain the Quality of Cell Cultures	2022.2.9
Organs-on-Chips: New science and standards for implementation	2021.12.7
EU REACH Regulation, EU Cosmetic Regulation, and New Animal Tests on Cosmetic Ingredients	2021.11.3
Bridging toxicology and research: COVID-19 initiatives	2021.7.27
Human Induced Pluropotent Stem Cells (hIPSC) in Toxicology	2021.7.7
International Computational Collaborations for Predictive Toxicology	2021.6.24
New Approach Methods in genotoxicity and mechanistic toxicity testing for the animal-free safety assessment of novel pharmaceuticals and chemicals	2021.6.15
Legal and Policy Considerations for the Use of New Approach Methodologies (NAMs) in Chemical Risk Assessment	2021.5.18
QIVIVE Tools and Case Studies	2021.3.5
Medical Device Assessment: Updates for Thrombogenicity and Skin Irritation	2021.2.2
Development of a Bayesian Network Model for Predicting Fish Acute Toxicity from Fish Embryo Toxicity Data	2020.12.11
Phenotypic profiling for high-throughput chemical screening at the U.S. EPA	2020.9.30
The Use of Machine Learning and Artificial Intelligence in Toxicology and Risk Assessment	2020.8.31
Human Biology-based Approaches for COVID 19 Therapeutics	2020.8.31
PubMed Abstract Sifter: A Literature Informatics Tool for Chemical Research	2020.8.31
Use of New Approach Methodologies for Cosmetic Safety Assessment without Animal Testing	2020.8.31

Emulate webinars

Title	Update
Dissecting Cancer-Microbiome Interactions with Organoids and Organ-Chips	2023.9.22

Scitovation webinars

Title	Update
A Source to Outcome Approach for Inhalation Risk Assessment: The Importance of Collaboration	2023.9.14
NAM-Driven Computational Pipelines for Safety and Regulatory Framework	2023.7.21
New Approach Methodologies (NAMs) for Genetic Toxicity Assessment and Regulatory Evaluation of New and Existing Substances	2023.3.1
Increasing scientific confidence in reliable and relevant approaches for regulatory testing – respiratory toxicity case study	2022.9.8

Cancer AI Research: Computational Approaches Addressing Imperfect Data (NCI)

Title	Update
Cancer AI Research: Computational Approaches Addressing Imperfect Data	2023.9.7

NC3Rs Webinar

Title	Update
CRACK IT Challenge webinar: An in vitro model of the human osteoarthritic joint	2023.8.3
Developments and future directions in regulatory fish acute toxicity testing	2022.10.20
Organ-on-a-chip technology-from a scientific and 3Rs perspective	2021.2.17
Scientific validity and EURL ECVAM recommendations for the replacements for animal-derived antibodies	2021.2.3

Derive a Point of Departure from In Vitro Methods for Use in Skin Sensitization Risk Assessment (IIVS)

Title	Update
Applications	2023.7.12
Model Development	2023.6.13

Evaluation of chemical-induced cardiotoxicity: challenges and progress (ALTERNATIVE)

Title	Update
Evaluation of chemical-induced cardiotoxicity: challenges and progress	2023.7.6

Use of New Approach Methodologies (NAMs) in Risk Assessment (PETA/PISC, US EPA, PCRM)

Title	Update
Ecotox: What can we do today?	2023.5.17
Frameworks for Establishing Scientific Confidence in New Approach Methodologies: PART II	2023.4.21
Frameworks for Establishing Scientific Confidence in New Approach Methodologies: PART I	2023.4.13
Data-Driven Solutions to Reducing Animal Use in Ecotoxicity	2022.7.19
Acceptance and Use of In Vitro and Ex Vivo Eye Irritation Test Methods	2022.1.14
Use of Computational and AOP-based Approaches to Inform Carcinogenicity Assessments	2021.3.16
Identification of New Approach Methodologies (NAMs) for Placement on the TSCA 4(h)(2)(C) List: A Proposed NAM Nomination Form	2020.10.7
Use of Non-animal Skin Sensitisation Test Methods	2020.6.10
CATMoS: Development and Use of the Collaborative Acute Toxicity Modeling Suite	2020.2.10
New Approaches for Fish Toxicity Testing	2019.12.1
New Approaches for Respiratory Sensitization	2019.5.7
MPPD and CFD Modeling to Predict Dosimetry of Inhaled Substances	2019.3.1
Use of Non-animal Methods for Skin Sensitisation Testing	2018.11.22

ICCVAM Communities of Practice Webinar: Non-animal Approaches for Mixtures Assessment

Title	Update
ICCVAM Communities of Practice Webinar 2023: Emerging Approaches for Anchoring Biological Relevance of New Approach Methodologies	2023.5.11
ICCVAM Communities of Practice Webinar on New Approach Methodologies to Assess (Developmental) Neurotoxicity	2022.3.24
ICCVAM Communities of Practice Webinar: Non-animal Approaches for Mixtures Assessment	2021.2.23

Using New Approach Methodologies to Address Variability and Susceptibility Across Populations (NICEATM)

Title	Update
Using New Approach Methodologies to Address Variability and Susceptibility Across Populations	2023.3.7
Chemical Exposure and Susceptible Populations	2023.2.22
Clinical Trials on Chips to Tackle Rare Diseases	2022.12.13
NAMs to Address Population Variability and Susceptibility	2022.11.15

Successful alternatives to animal testing (Elsevier)

Title	Update
Successful alternatives to animal testing	2023.2.9

Animal-free Risk Assessment for Cosmetics (AFSA)

Title	Update
Global Cosmetic Regulatory Landscape	2022.10.12
Dosimetry: Internal Exposure and IVIVE	2022.8.26
Predictive Chemistry: In Silico Tools and Read-across	2022.8.10
Consumer Exposure	2022.7.20

3D Tissue Models for Antiviral Drug Development (NIH-NCATS, NIAID)

Title	Update
3D Tissue Models for Antiviral Drug Development	2022.9.14

Current Concepts in Quantitative Risk Assessment for Skin Sensitization (NICEATM, SCAHT, SECO)

Title	Update
Current Concepts in Quantitative Risk Assessment for Skin Sensitization	2022.5.31

Title	Update
NC3Rs「10 years of CRACK IT」 -The worm that turned the tide on in vivo DART testing -Virtual laboratories for non-animal disease research and toxicity testing -Chipping away at in vivo nephrotoxicity testing -Putting in vitro platforms at the heart of cardiotoxicity testing -3D retinal organoids - a vision of the future -Using microfluidics to eliminate surgical embryo transfer in mice -Assessing the genotoxic potential of gene therapy products in vitro	2021.12.20

-The worm that turned the tide on in vivo DART testing
-Virtual laboratories for non-animal disease research and toxicity testing
-Chipping away at in vivo nephrotoxicity testing
-Putting in vitro platforms at the heart of cardiotoxicity testing
-3D retinal organoids - a vision of the future
-Using microfluidics to eliminate surgical embryo transfer in mice
-Assessing the genotoxic potential of gene therapy products in vitro

2021.12.20

Accelerating Global Deletion of the Abnormal Toxicity Test (AFSA, EFPIA, HSI, IABS)

Title	Update
Accelerating Global Deletion of the Abnormal Toxicity Test	2021.12.14

Webinar on Inhalation Toxicity Testing (PSCI, US EPA)

Title	Update
2021 Webinar on Inhalation Toxicity Testing	2021.6.11
2020 Webinar on Inhalation Toxicity Testing	2021.2.25

PSIS 2021 Online Workshop - Organ on Chip: Towards Standardization(JRC, CEN, CENELEC)

Title	Update
PSIS 2021 Online Workshop - Organ on Chip: Towards Standardization	2021.6.9

Updates on Activities Related to 21st Century Toxicology(CAAT, AFSA)

Title	Update
Updates on Activities Related to 21st Century Toxicology	2021.6.3

Microphysiological Systems for COVID Research(NICEATM, NC3Rs)

Title	Update
MPSCoRe Spring Workshop: April 2021	2021.5.31
MPSCoRe Organizational Meeting: January 2021	2021.3.17

The Innovative (In vitro) Cell-based Assays for Drug Discovery (Xconomy Insight/Eurofins Discovery)

Title	Update
Screening Approaches for Reducing Attrition Due to Drug-induced Liver Injury (DILI) Early in Drug Discovery	2021.2.18
High-Throughput Assessment of Compound-Induced Cardiotoxicity Using Human iPSC-Derived Cardiomyocytes	2021.2.9
Challenges of Incorporating Non-Animal Preclinical Data into Drug Regulatory Applications	2021.1.19

Animal-free Recombinant Antibodies, rAbs (PETA/PISC, NICEATM, EURL ECVAM)

Title	Update
Accessibility of animal-free antibodies	2020.11.20
Application of Animal-free Antibodies	2020.11.20
Scientific and Economic Benefits of Animal-free Antibodies	2020.9.28
Animal-free Antibodies Against Diseases: Rapid Response to Fight Covid-19	2020.8.3

The Integrated Chemical Environment: Tools and Data to Support Toxicity Assessments (PETA/PISC, NICEATM)

Title	Update
The Integrated Chemical Environment: Tools and Data to Support Toxicity Assessments	2020.2.17

In Vitro Assays for Dermal Safety (PETA/PISC, IIVS)

Title	Update
Non-regulatory In Vitro Assays Used for Dermal Safety and Eficacy Test	2018.10.29
In Vitro Assays for Dermal Safety and Efficacy Testing for Regulatory and Non-regulatory Purposes	2018.10.23

OECD webinars

Title	Topic	Update
Integrated Approaches to Testing and Assessment (IATA): concepts and OECD case studies		2023.4.27
Recent Improvements And Future Challenges For The Adverse Outcome Pathway (AOP) Framework And The AOP-WIKI		2023.4.24
Implementation of the first stand-alone NAMs for eye hazard identification into OECD Guidelines: OECD GL 467 and TG 492B		2022.12.20
Gaining Acceptance in Next Generation PBK Modelling Approaches for Regulatory Assessments		2022.5.11
Building trust in the scientific evidence base supporting chemical risk assessment and the role of the AOP Framework		2022.4.25
Webinar on AOP co-operative activities between Scientific journals and the OECD		2022.3.29
OECD QSAR Toolbox applications for REACH and beyond		2022.2.16
Implementation of the Defined Approaches on Skin Sensitisation (OECD GL 497) for chemical safety in member countries		2021.12.27
Testing and Assessment Methodologies- Adverse Outcome Pathway, AOP	Adverse Outcome Pathways Knowledge Base (AOP-KB) and AOP Developing Tips	2020.5.4
	AOPs: Assembling and Evaluating Weight of Evidence and Quantitative Understanding	2020.4.20
	Next Generation Knowledge: Adverse Outcome Pathway (AOP) Framework as a Collaborative Tool	2020.4.6

CAAT Webinars

Title	Topic	Update
Alternative approaches in Developmental Neurotoxicity		2022.3.2
3Rs Training Series Webinar: Innovative Respiratory Models		2022.2.8
MPS World Summit Virtual Pre-Event	Towards Regulatory Acceptance -Standardization, scaling-up, and quality control of platforms and cell sources -Obstacles to accomplishing regulatory acceptance	2022.1.24
MPS World Summit Virtual Pre-Event	Systems engineering of Microphysiological Systems -MPS Hardware and enabling Technologies -Cell models and applications for MPS-	2022.1.24
Challenges and Opportunities for Overcoming Dog Use in Agrochemical Evaluation and Registration	The value of the 90-day dog study in pesticide registration toxicity testing in the U.S.	2022.1.11
	Incorporating toxicokinetic and toxicity data to evaluate the value added from using dogs in subchronic toxicity testing for agrochemicals
	Relevance of dog studies for the derivation of health-based guidance values for Plant Protection Products Approval – EFSA
	Species Liver-Chip to assess cross-species drug toxicity and human relevance
	Origins, History, Utility, and Future of Canine Bioassays in Pharmaceuticals R&D

Lush Prize Conference

Title	Update
Lush Prize Conference 2022	2023.3.21
Lush Prize Conference 2021：The Role of Public Awareness in the Replacement of Animals In Safety Testing	2022.1.3

ICCVAM Public Forum

Title	Update
ICCVAM Public Forum 2022 -Welcome and Introductions -Consumer Product Safety Commission Guidance on New Approach Methodologies -USDA Animal Welfare Information Center -EPA Activities on NAMs: Update from the Office of Pesticide Programs -EPA Office of Research and Development: Update on Alternatives Research Activities -Regulatory Science Tools for Accelerating Innovation in Toxicology Reviews -FDA Update on Advancing Alternatives for Regulatory Use -OECD Test Guidelines Programme Update -3Rs Assessment of Animal Toxicity Data -Carcinogenicity Testing for the 21st Century -Activities of the Developmental Neurotoxicity Health Effects Innovation Program -Microphysiological Systems Applications for Predictive Toxicology -Investigating DNA Adduct Formation by Flavor Chemicals and Tobacco Byproduct in E-cigarettes Using In Silico Approaches -EPA Activities on New Approach Methods: Update from the Office of Pollution Prevention and Toxics -NICEATM Update -ICCVAM Workgroup Updates -Measurement Science in ICCVAM -Cardiovascular Health Effects Innovation Program Update	2022.8.8
ICCVAM Public Forum 2021 -Welcome and Introductions -NICEATM and NTP Update -ICCVAM Workgroup Updates -Consumer Product Safety Commission Guidance for Industry and Test Method Developers -USDA Animal Welfare Information Center -Application of NAMs, Surrogates, and Read-across in Rapid Development of PBPK Models for Human Health Risk Assessment -Investigation of Parathion-induced Neurotoxicity in SHSY5Y Cells Demonstrates Utility of the Assay as an Alternative Animal Model -Assessment of Acute Oral Toxicity for Mixtures Using In Silico Modeling Methods -Alternative Approaches to Ecotoxicological Testing and Assessment -Impact of Alternatives to Animals in VA Research -Update on EPA ORD New Approach Method Research Activities -Recent Progress Towards Reducing Animal Use & Adopting NAMs at EPA's Office of Pesticide Programs -OPPT's Progress Implementing the Near-term Activities in the TSCA Strategic Plan -Advancing Alternative Methods at FDA -Measurement Science Activities Under ICCVAM -OECD Test Guidelines Programme Update	2021.7.20
ICCVAM Public Forum 2020 -Welcome and Introductions -Reflections on 20 Years of ICCVAM -ICCVAM Workgroup Updates -NICEATM Update -Update on FDA Activities on Alternative Methods -IATA for Developmental Neurotoxicity -Update on Alternatives Research Activities at EPA -EPA Office of Pesticide Programs -Update from EPA/OSCPP/OPPT -USDA Animal Welfare Information Center -59MDW Science and Technology Overview and Upcoming Toxicology Projects -OSHA Update to ICCVAM -NCATS Update on Tox21 Activities -Measurement Science Activities Under ICCVAM -OECD Test Guidelines Programme Update	2020.5.21

CAAT 40th Anniversary Symposium

Title	Update
CAAT 40th Anniversary Symposium -Developmental NeuroToxicity (DNT) -Evidence-based Toxicology Collaboration (EBTC) -Good Cell Culture Practice (GCCP) Program -Green Toxicology -Cosmetic and TestSmart Program -Education program -Refinement Program -World Congress on Alternatives -Policy Program -Future Perspectives	2022.1.19

3Rs across Europe webinar series

Title	Topic	Update
2021 Cross-European 3Rs webinar series	Replacing basement membrane extracts (BMEs): An introduction BMEs and replacements from a research perspective Touching on diagnostics, regenerative medicine and the regulatory aspects of replacing BMEs The future of BMEs and their replacements: A panel discussion	2022.1.7
3Rs across Europe webinar series 2020	9⁄22 Webinars -Organoids and Single Cell Analyses as Tools to Substitute Mouse Models in Cancer Research -Pain management and assessment in mouse femoral fracture models -BEHAVE: Developing a toolkit for deep-behavior profiling of laboratory rodents -Fish cell lines and the 3Rs: fundamental developments and application in chemical risk assessment	2020.10.16
	9⁄23 Webinars -Supraglottic airway devices as a means of refining laboratory animal anaesthesia -Development of a new in vitro metastasis assay -An in vitro method to predict sudden adverse lung effects -QSAR modeling of chemical substances’ possible interference with the thyroid hormone system
	9⁄24 Webinars -A guideline for marking and tagging fish -Let your digital twin become your own personalized guinea pig -Developing a complex model of bone formation -Reducing the use of animals for studying transmission of respiratory viruses

3Rs Symposium (AWIC, OLAW, JHMI-MCP, CAAT)

Title	Topic	Update
2021, 8th Annual 3Rs Symposium: Pandemic-Driven Advances	NCATS: NIH: Translating Disruptive Technologies from Microphysiological Systems to Electronic Noses	2021.9.8
	Redefining Facility Operations & the Utilization of Performance Standards in Animal Husbandry & Care
	How COVID Spotlights the Model Dilemma in Biomedical Research
	Harmonizing Coronavirus Research Across NPRCs: Coronavirus Vaccine & Therapeutic Evaluation Network
	Elements of a Systematic Process for Literature Searching: a 3Rs-based Example
	The Evolution of the 3Rs: Reflections on Art, Ethics, and Science
	Facial Cues for Assessing Welfare in Primates
	Ally or Enemy: Machine Learning and the 3Rs
	Assessing Pain in Small Laboratory Rodents to Improve Animal Welfare
	Measuring and Enhancing Welfare through Voluntary Training Tasks
The 7th Annual 3Rs Symposium: Practical Solutions and Success Stories	Minibrain Organoids	2021.1.6
	Innovative Models in Biomedical Research: A Literature Review
	Other

Microphysiological Systems: Bridging Human and Animal Research - A Workshop (NASEM, ILAR)

Title	Update
Welcome Remarks	2021.2.22
MPS for Toxicology Testing
Going from In Vitro to In Silico - Data and Developmental Tools
Panel Discussion on Topics of Public Health Importance (COVID)/a>
Commercialization / Engineering / Collaborations
Multi-Organ Chips and Emerging Application for Biologics Studies
Closing Remarks

International Symposium on Alternatives Assessment: Current Practices and Future Prospects

Title	Update
10⁄27 Webinars -Updates from Europe Part I: Programs advancing informed substitution -Industry experience implementing alternatives assessment and substitution Part I: Lessons learned from large multi-nationals	2021.1.4
10⁄28 Webinars -Updates from Europe Part II: Safe-By-Design -Industry experience implementing alternatives assessment and substitution Part II: Lessons learned from small business users of chemicals
10⁄29 Webinars -Part I: Considering Uncertainty: Real-world strategies to make decisions -Part II: Considering Trade-offs: Real-world strategies to make decisions(no video)

Conference on the State of the Science on Development and Use of New Approach Methods (NAMs) for Chemical Safety Testing(U.S. EPA)

Title	Update
10⁄19 Webinars -Overview of EPA NAMs Work Plan -Progress on Implementing the TSCA Alternatives Strategic Plan -Using Chemical, Biological, and In Vivo Data for NAMs: Which data do we have, and what can we do with it? -Transcriptome-Based Derivation of an In Vivo POD: Current and Future Utility -Drugmonizome and Drugmonizome-ML: Integration and Abstraction of Small Molecule Attributes for Drug Set Enrichment Analysis and Machine Learning -"Fit for Purpose" for Organotypic Models in Environmental Health Protection	2020.12.2
10⁄20 Webinars -Retrofitting an Estrogen Receptor Transactivation Assay with Metabolic Competence -In Vitro Disposition of Tox21 Chemicals: Initial Results and Next Steps -An OECD Harmonized Template (OHT) to Report NAM Results in Regulatory Environments: Principles and Practical Use -Case Study #1: Integration of NAM Data for Evaluating Potential Developmental Neurotoxicity -Case Study #2: Integration of NAM Data in a Next Generation Risk Assessment for Cosmetic Ingredients -Case Study #3: Incorporating the Threshold of Toxicological Concern into Regulatory Decisions under the Amended Toxic Substances Control Act	2020.12.2

Title

Update

10⁄19 Webinars

-Overview of EPA NAMs Work Plan
-Progress on Implementing the TSCA Alternatives Strategic Plan
-Using Chemical, Biological, and In Vivo Data for NAMs: Which data do we have, and what can we do with it?
-Transcriptome-Based Derivation of an In Vivo POD: Current and Future Utility
-Drugmonizome and Drugmonizome-ML: Integration and Abstraction of Small Molecule Attributes for Drug Set Enrichment Analysis and Machine Learning
-"Fit for Purpose" for Organotypic Models in Environmental Health Protection

2020.12.2

10⁄20 Webinars

-Retrofitting an Estrogen Receptor Transactivation Assay with Metabolic Competence
-In Vitro Disposition of Tox21 Chemicals: Initial Results and Next Steps
-An OECD Harmonized Template (OHT) to Report NAM Results in Regulatory Environments: Principles and Practical Use
-Case Study #1: Integration of NAM Data for Evaluating Potential Developmental Neurotoxicity
-Case Study #2: Integration of NAM Data in a Next Generation Risk Assessment for Cosmetic Ingredients
-Case Study #3: Incorporating the Threshold of Toxicological Concern into Regulatory Decisions under the Amended Toxic Substances Control Act